🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to understand the effects of everolimus on tac...
Status
Completed
Location
National Taiwan University Hospital
Start Date
2014-04
Trial ID
NCT02077556
Treatments Being Tested
This study is designed to assess the safety and efficacy of RAD001 monother...
Status
Completed
Location
Highlands Oncology Group DeptofHighlandsOncologyGrp(2)
Start Date
2009-07
Trial ID
NCT00879333
Treatments Being Tested
The aim of this study is to evaluate the clinical efficacy of everolimus as...
Status
Recruiting
Location
Xuanwu Hospital, Beijing
Start Date
2026-07-01
Trial ID
NCT07095933
Treatments Being Tested
Transplant rejection occurs when a patient's body does not recognize the ne...
Status
Completed
Location
University of Wisconsin - Department of Medicine
Start Date
2003-11
Trial ID
NCT00078559
Anti-rejection medicines, also known as immunosuppressive drugs, are prescr...
Status
Completed
Location
Duke University Health System
Start Date
2018-07-30
Trial ID
NCT03504241
The purpose of this study is to compare treatment with RAD001 plus best sup...
Status
Completed
Location
Highlands Oncology Group Dept of Highlands Oncology Grp
Start Date
2010-04
Trial ID
NCT01035229
Treatments Being Tested
The present multi-center, open-label, single-arm study aims to evaluate the...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-06
Trial ID
NCT01626222
Treatments Being Tested
In the present study, the investigators propose a conversion scheme with 50...
Status
Terminated
Location
Hospital São João de Deus/Fundação Geraldo Corrêa
Start Date
2013-03
Trial ID
NCT01609673
Treatments Being Tested
RATIONALE: Everolimus may stop the growth of tumor cells by blocking some o...
Status
Terminated
Location
University of California Davis Cancer Center
Start Date
2009-03
Trial ID
NCT00807755
Treatments Being Tested
Background: Blood cancers (such as leukemias or lymphomas) often do not re...
Status
Recruiting
Location
City of Hope
Start Date
2022-11-18
Trial ID
NCT05436418